Dentsply Sirona Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Dentsply Sirona Inc 's ROA in the second quarter of 2026?
Dentsply Sirona Inc recorded a cumulative net loss of $-547 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -10.14%.

However, within the Healthcare sector 293 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 3237, from total ROA ranking in the first quarter of 2026 at 3760.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Total Assets Change	-13.26 %	-13.57 %	-5.63 %	-14.68 %	-12.01 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-547	-627	-598	-881	-948
Return On Assets (TTM)	-10.14 %	-11.21 %	-10.31 %	-14.98 %	-15.48 %
XRAY's Total Ranking	# 3237	# 3760	# 3434	# 3460	# 3479
Total Assets (TTM) in million	5,264	5,229	5,429	5,653	6,069
Seq. Total Assets Change	0.67 %	-3.68 %	-3.96 %	-6.85 %	0.31 %
Seq. Net Income Change	-	-	-	-	-

XRAY's 5 Years Annual ROA >> Back to XRAY Management Effectiveness >> Compare XRAY ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 95
Sector	# 294
Overall	# 3170

Return On Assets Statistics
High	Average	Low
19.27 %	0.11 %	-29.27 %
(March 31, 2008)		(Sep 30 2018)

Financial Statements
Dentsply Sirona Inc 's Assets	$ 5,264 million	XRAY's Balance sheet
Dentsply Sirona Inc 's Income	$ 36 million	Quarterly XRAY's Income Statement
XRAY's Income by Division		See XRAY's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	-5.63 %	-20.12 %	-5.77 %	-17.27 %	-0.98 %
Total Assets in million	5,429	5,753	7,202	7,643	9,239
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-598	-910	-132	-950	411
Annual Return On Assets	-11.01 %	-15.82 %	-1.83 %	-12.43 %	4.45 %

XRAY's 5 Years Annual ROA >> Back to XRAY Management Effectiveness >> Compare XRAY ROA to its Competitors

More Return On Assets Ratios
XRAY's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
XRAY's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for XRAY's Competitors
Subscribers only: Roa for Dentsply Sirona Inc 's Suppliers
Subscribers only: Return On Assets for XRAY's Customers

You may also want to know
XRAY's Roi	XRAY's Inventory Turnover Ratio	XRAY's Growth Rates	XRAY's Dividend Comparisons
	XRAY's Profitability Ratios	XRAY's Asset Turnover Ratio	XRAY's Dividend Growth
XRAY's Roe	XRAY's Valuation Ratios	XRAY's Financial Strength Ratios	XRAY's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector

ROA

Date modified: 2026-09-08T15:11:45+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.